| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $651.5M | -18.7% |
| Cost of Revenue | $432.4M | -18.4% |
| Gross Profit | $219.2M | -19.2% |
| R&D Expense | $126.8M | -31.8% |
| SG&A Expense | $56.4M | -5.8% |
| Operating Income | -$83.3M | +38.3% |
| Pre-tax Income | -$91.4M | +31.3% |
| Income Tax | $2.0M | -99.3% |
| Net Income | -$93.5M | +78.4% |
| EPS (Diluted) | -$0.59 | +79.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $49.7M | -51.7% |
| Accounts Receivable | $93.5M | +8.8% |
| Inventory | $78.4M | -35.0% |
| Current Assets | $252.6M | -25.5% |
| Total Assets | $428.0M | -21.3% |
| Current Liabilities | $277.2M | -22.2% |
| Long-term Debt | $44.3M | — |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.7M | +83.5% |
| Capital Expenditures | $3.4M | -16.8% |
| Investing Cash Flow | -$3.4M | -143.9% |
| Financing Cash Flow | -$30.1M | -3141.3% |
| Free Cash Flow | -$24.0M | +81.4% |
| $351.4M |
| -10.3% |
| Stockholders' Equity | $76.5M | -49.5% |